Safety of a Second Dose of Biken's Varicella Vaccine Administered at 4 to 6 Years of Age in Healthy Children in Argentina.

Trial Profile

Safety of a Second Dose of Biken's Varicella Vaccine Administered at 4 to 6 Years of Age in Healthy Children in Argentina.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2013

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Chickenpox
  • Focus Adverse reactions
  • Sponsors Sanofi
  • Most Recent Events

    • 10 Apr 2010 Actual patient number (122) added as reported by ClinicalTrials.gov.
    • 10 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Jan 2010 Planned end date changed from 1 Nov 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top